A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors
Conditions: Advanced or Metastatic Solid Tumors; Breast Cancer; Recurrent Ovarian Cancer; Prostate Cancer Interventions: Drug: VIO-01 Sponsors: Valerio Therapeutics Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Ovarian Cancer | Ovaries | Prostate Cancer | Research | Study